SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Fortrea Sees Higher Evidence Bar for Oncology Drug Development

Fortrea’s ESMO 2026 analysis describes a higher evidence bar for oncology drug development.

FTRE

Related stories